BOTTA-FRIDLUND , Danielle

Last name: BOTTA-FRIDLUND

First name: Danielle

November 2017 (v1)

Journal article

Metadata-only

Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

Dharancy, Sébastien Coilly, Audrey Fougerou-Leurent, Claire

Hepatitis C virus (HCV) infection is associated with reduced patient survival following combined liver-kidney transplantation (LKT). The aim of this study was to assess the efficacy and safety of second-generation direct-acting antivirals (DAAs) in this difficult-to-treat population. The ANRS CO23 "Compassionate use of Protease Inhibitors in...

Uploaded on: February 28, 2023
2017 (v1)

Journal article

Metadata-only

Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.

Houssel-Debry, Pauline Coilly, Audrey Fougerou-Leurent, Claire

Meeting Abstract: 925

Uploaded on: February 28, 2023
October 2016 (v1)

Journal article

Metadata-only

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study

Coilly, Audrey Fougerou-Leurent, Claire Ledinghen, Victor

Background & Aims:HCV recurrence remains a major issue in the liver transplant field, as it has a negative impact on both graft and patient survival. The purpose of this study was to investigate the efficacy and safety of treating HCV recurrence with sofosbuvir (SOF) and daclatasvir (DCV) combination therapy. Methods: From October 2013 to March...

Uploaded on: February 28, 2023

BOTTA-FRIDLUND , Danielle

Recent uploads